Celldex Therapeutics (CLDX) Q3 2019 Earnings

7AugConfirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-2.22
-1.68
-1.14
-0.6

Details

Expected EPS
-1.17
Actual EPS
-0.84
Surprise EPS
0.33
Surprise Percent
+28.21%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.84 per share for Q3 2019.

0 Comments

Share your thoughts